CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.

Koofhethile, Catherine Kegakilwe.Ndhlovu, Zaza Mtine.Thobakgale, Christina Fanesa.Prado, Julia G.Ismail, Nasreen.Mncube, Zenele.Mkhize, Lungile.Van der Stok, Mary Elizabeth.Yende-Zuma, Fortunate Nonhlanhla.Walker, Bruce D.Goulder, Philip Jeremy Renshaw.Ndung'u, Peter Thumbi.2018-07-112018-07-1120162016Koofhethile, C.K., Ndhlovu, Z.M., Thobakgale-Tshabalala, C., Prado, J.G., Ismail, N., Mncube, Z., Mkhize, L., van der Stok, M., Yende, N., Walker, B.D., Goulder, P.J. and Ndung’u, T. 2016. CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles. Journal of virology, 90(15), 6818-6831.http://dx.doi.org/10.1128/JVI.00276-16http://hdl.handle.net/10413/15359CAPRISA, 2016.Abstract available in PDF file.enCD8-Positive T-Lymphocytes--Drug effects.HIV Infections--Drug therapy.HIV Infections--Virology.CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.Peer reviewed journal article